欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0493/002
药品名称Femsira
活性成分
    • dimethyl fumarate 240.0 mg
剂型Gastro-resistant capsule, hard
上市许可持有人AdAlvo Limited Malta Life Science Park, Level 1, Building 4, Sir Temi Zammit Buildings, San Gwann, SGN 3000, Malta
参考成员国 - 产品名称Iceland (IS)
Adfegy / Femsira / Refuma
互认成员国 - 产品名称
    • Lithuania (LT)
      Mudisa 240 mg skrandyje neirios kietosios kapsulės
    • Malta (MT)
      Mudisa 240 mg gastro-resistant hard capsules
    • Latvia (LV)
许可日期2023/01/02
最近更新日期2024/07/22
药物ATC编码
    • L04AX07 dimethyl fumarate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase